Eldon C. III Mayer
CIK 1686952 · Ex VP & Chief Commerc. Officer · last filed 2023-03-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$5.42M
Companies
2
Total Filings
25
Lifetime Open-Market Net
$882.9K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Ex VP & Chief Commerc. Officer | 56,073 | $1.73 | $96.7K | $275.0K | 16 | 2023-03-21 |
| RIGL | EVP & Chief Commercial Officer | 165,000 | $32.85 | $5.42M | $607.9K | 9 | 2019-11-20 |
Recent Filings · Page 3 of 3
25 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-03-16 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-26 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2018-01-09 | Eiger BioPharmaceuticals, Inc. (EIGR) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-06 | RIGL | Grant (A) | — | $0 | EDGAR |
| 2016-10-11 | RIGL | Grant (A) | — | $0 | EDGAR |
Showing 21–25 of 25
Prev
Page 3 of 3
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.